Moors & Cabot’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265K | Buy |
+5,455
| New | +$265K | 0.01% | 696 |
|
|
2024
Q2 | – | Sell |
-2,963
| Closed | -$202K | – | 861 |
|
|
2024
Q1 | $202K | Sell |
2,963
-620
| -17% | -$42.3K | 0.01% | 813 |
|
|
2023
Q4 | $224K | Buy |
+3,583
| New | +$224K | 0.01% | 715 |
|
|
2021
Q4 | – | Sell |
-2,035
| Closed | -$228K | – | 861 |
|
|
2021
Q3 | $228K | Buy |
2,035
+150
| +8% | +$16.8K | 0.01% | 704 |
|
|
2021
Q2 | $305K | Buy |
1,885
+145
| +8% | +$23.5K | 0.02% | 561 |
|
|
2021
Q1 | $212K | Buy |
+1,740
| New | +$212K | 0.02% | 663 |
|